Testicular tumors [DS:H00023] Ovarian tumors [DS:H00027] Bladder cancer [DS:H00022]
Comment
platinum compound
DNA alkylator
Target
DNA
Metabolism
Transporter: SLC22A2 [HSA:6582]
Interaction
Structure map
map07040
Antineoplastics - alkylating agents
Other map
map01524
Platinum drug resistance
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XA Platinum compounds
L01XA01 Cisplatin
D00275 Cisplatin (JP18/USP/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D00275 Cisplatin (JP18/USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01679 Platinum compound
D00275 Cisplatin
Transporter substrate
DG02854 SLC22A2 substrate
D00275 Cisplatin
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00275 Cisplatin
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D00275
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00275
Other DBs
CAS:
15663-27-1
PubChem:
7847341
ChEBI:
27899
PDB-CCD:
CPT[PDBj]
NIKKAJI:
J277.914E
KCF data
ATOM 5
1 Z Pt 34.5801 -25.8301
2 X Cl 35.9846 -25.8301
3 X Cl 34.5743 -27.2286
4 N0 N 31.9200 -25.8300
5 N0 N 33.8100 -24.0800
BOND 2
1 1 2 1
2 1 3 1